Enzon Pharmaceuticals Inc ENZN:OTCQX

RT Quote | Exchange | USD
Last | 2:37 PM EDT
0.29quote price arrow down-0.01 (-3.3333%)
Volume
2,500
52 week range
0.25 - 0.76
Loading...
  • Open0.29
  • Day High0.29
  • Day Low0.29
  • Prev Close0.30
  • 52 Week High0.76
  • 52 Week High Date06/15/21
  • 52 Week Low0.25
  • 52 Week Low Date03/14/22

Key Stats

  • Market Cap21.52M
  • Shares Out74.21M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.06
  • YTD % Change-12.41

KEY STATS

  • Open0.29
  • Day High0.29
  • Day Low0.29
  • Prev Close0.30
  • 52 Week High0.76
  • 52 Week High Date06/15/21
  • 52 Week Low0.25
  • 52 Week Low Date03/14/22
  • Market Cap21.52M
  • Shares Out74.21M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.06
  • YTD % Change-12.41

RATIOS/PROFITABILITY

  • EPS (TTM)-0.04
  • P/E (TTM)-7.64
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-777,000.00
  • ROE (TTM)-51.67%
  • Revenue (TTM)320,000.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-240.94%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date09/30/2019
  • Div Amount0.12
  • Split Date-
  • Split Factor-

Latest On Enzon Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Enzon Pharmaceuticals, Inc. (Enzon) is an acquisition vehicle company. The Company intends to become an acquisition platform. The Company utilizes its net operating loss carryforwards (NOLs) and improves stockholder value. It manages its source of royalty revenues from existing licensing arrangements with other companies.
Randolph Read CPA
Independent Chairman of the Board
Richard Feinstein
Chief Executive Officer, Chief Financial Officer, Company Secretary
Address
20 Commerce Drive, Suite 135
Cranford, NJ
07016
United States

Top Peers

SYMBOLLASTCHG%CHG
CDTX
Cidara Therapeutics Inc
0.4527+0.0118+2.68%
ENVB
Enveric Biosciences Inc
0.208+0.008+4.00%
PLX
Protalix Biotherapeutics Inc
1.15+0.05+4.09%
MTEM
Molecular Templates Inc
1.02+0.05+5.52%
ANGN
Angion Biomedica Corp
1.45+0.13+9.85%
ORGS
Orgenesis Inc
2.51+0.05+2.03%